Vancomycin dosing required to achieve a therapeutic level in children post-surgical correction of congenital heart disease

The vancomycin dosing range for safe and effective treatment remains uncertain for children who had corrective surgery for a congenital heart disease (CHD). We aimed to determine the vancomycin dosing requirements for this subgroup of patients. This prospective cohort study included children younger...

Descripción completa

Detalles Bibliográficos
Autores principales: Alakeel, Yousif S., Alanazi, Ghadah A., Alawbathani, Bushra S., Alshutwi, Kadi I., Alahmed, Yazeed S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575798/
https://www.ncbi.nlm.nih.gov/pubmed/36254077
http://dx.doi.org/10.1097/MD.0000000000030145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575798/
https://www.ncbi.nlm.nih.gov/pubmed/36254077
http://dx.doi.org/10.1097/MD.0000000000030145

Ejemplares similares